Each year, the number of medical devices and drugs on the market increases, and so do the recalls and safety alerts. In addition to recalls made by the U. S. Food and Drug Administration (FDA), manufacturers also “voluntarily” pull problematic products off the market. As a consumer, it is important to be aware of devices or drugs that may affect your health.
Thousands of women received mesh implants to treat pelvic organ prolapse or stress urinary incontinence. Many had corrective surgery, and some mesh manufacturers pulled their products.
Studies link this best-selling type 2 diabetes medication to bladder cancer, and it was recalled in Germany and France. The FDA has not issued a recall in the United States.
After taking these birth control pills, thousands of women suffered serious complications. FDA studies show a 74 percent increased risk of dangerous blood clots, prompting advocates to call for a recall.
This popular acne medication was recalled after it was linked to a number of side effects, including birth defects, Crohn’s disease and suicidal thoughts.
Millions of Americans took this painkiller. After several years on the market, the drug was recalled because it increased the risk of heart attack and stroke and was linked to more than 38,000 deaths.
Transvaginal mesh manufacturer Coloplast recently agreed to pay $16 million to settle hundreds of legal claims related to its mesh products, a move that could open the door to a wave of settlements in cases pending against companies fending off [...]
The many groups sounding warnings about Testosterone Replacement Therapy welcomed two surprising allies to their side in the battle over the controversial prescription drugs. The Nevada State Athletic Commission, which oversees boxing and mixed martial arts in that state, banned use [...]
The U.S. Food and Drug Administration (FDA) is warning doctors and consumers that a supplement used to treat genetic disorders in children can cause serious harm and in some cases could lead to death. New York-based compounding firm Medisca recently [...]